Apollo Hospitals is committed in finding cures and treatments for cancer in India. Read all about the unwavering will, our vision and team support to fight cancer
BLK Hospital is leading prostate cancer treatment center in Delhi, India and offers best cancer treatment hospital & surgery in India using latest procedures by best cancer doctors. It is one of the top cancer hospitals in India catering to a huge volume of patients.
Neck pain is a common problem. everyone survive this issue but you know what is the neck pain cancer if you don't know so read this article here full information about neck pain cancer and neck pain symptoms and cases also. If you are intrested so read this article.
The most common type of cancer found in women is the breast cancer. It is the leading cause of death in women all across the world. With this article, we will take a comprehensive look at the various aspects of breast cancer including its symptoms and causes.
Know more about breast cancer causes, symptoms, and treatment Breast cancer can be diagnosed through multiple tests, including a mammogram, ultrasound, MRI, and biopsy.
Yes males can also have breast cancer. The incidence is far less than females. So over all it is very rare. Less than 1% of all breast cancer cases occur in men.
For more information related to cancers, you can contact me on the below numbers for an appointment 8130128241 / 8586930175 Or email me priyatiwari.dr@gmail.com
For more information related to Prostate Cancer and other cancers, you can contact me on the below numbers for an appointment. 8130128241 / 8586930175 Or email me priyatiwari.dr@gmail.com
Should cancer patients take the Covid-19 vaccine? How many types of vaccines are available in India. Best Cancer Treatment Hospital is available in Gurgaon, Gurugram, Haryana, Delhi
The World Health Organisation (WHO) estimates that breast cancer, the leading cause of cancer-related deaths among women, impacts approximately 2.1 million women each year.
An oral drug combination by Novartis showed promise in treating a subgroup of patients suffering from a common childhood brain cancer in a trial.
In the mid-stage trial, 47 per cent of the patients that were given the two drugs Tafinlar and Mekinist saw their tumours shrink, far above a rate of 11 per cent
in a comparative group of participants on standard chemotherapy, the drugmaker said on Monday, June 6.
The participants, aged one to 17 years, were suffering from low-grade gliomas (LGG), the most common childhood brain cancer.
The trial only included those who were found to have a mutation known as BRAF V600, a genetic contributor in about 15 per cent to 20 per cent of paediatric LGG cases.
Among further results of the trial with 110 participants, the median time without disease progression was 20.1 months for those given the Novartis drug combo,
compared to 7.4 months on chemotherapy.
The new oral treatment candidate also caused less severe side effects than burdensome chemotherapy.